Skip to main content
Aditya Shreenivas, MD, Oncology, Duarte, CA

AdityaVarnamShreenivasMDMS

Oncology Duarte, CA

Physician

Overview of Dr. Shreenivas

I am a medical oncologist with a clinical practice in gastrointestinal and rare cancers. From a research standpoint, I am primarily affiliated with City of Hope 's early drug development program. Our group believes in the concept of vertical research, and the overall thrust of my research work has been focused on creating a small but significant impact in a few areas of oncology. They are as follows: 1) improve our understanding of radiation and immunotherapy resistance patterns and develop clinical trial concepts of novel multimodal therapeutic approaches in head& neck and gastrointestinal cancers. 2) develop pilot projects to better understand the role of tumor-informed circulating tumor DNA assays in response assessments. 3) utilization of individualized and personalized molecular-based therapies for the management of rare cancers, and finally 4) survivorship care and symptom management.

Education & Training

  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 2015 - 2018
  • BronxCare Health System
    BronxCare Health SystemResidency, Internal Medicine, 2012 - 2015
  • JSS Medical College Mysore
    JSS Medical College MysoreClass of 2010
  • Icahn school of medicine Newyork
    Icahn school of medicine Newyork MSCR, Clinical research

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2024 - 2026
  • WI State Medical License
    WI State Medical License 2018 - 2025
  • NY State Medical License
    NY State Medical License 2015 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Lectures

  • Racial disparities in palliative and hospice care beliefs of lung cancer patients. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Press Mentions

  • Their cancers can't be cured. But new treatments are increasing the length, and quality, of their lives.
    Their cancers can't be cured. But new treatments are increasing the length, and quality, of their lives.June 13th, 2024
  • Keeping Ahead of Oncology Advances Requires Vigilance
    Keeping Ahead of Oncology Advances Requires VigilanceSeptember 11th, 2018

Grant Support

  • Cancer Center Pilot GrantMedical College of WisconsinPresent
  • NRG NCORP GrantNRGPresent